Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

It’s important to keep tight controls on benzodiazepines

Samuel Ridout, MD, PhD
Meds
April 15, 2019
152 Shares
Share
Tweet
Share

When I completed my residency training in 2017 I never imagined so much of my clinical efforts would be directed towards educating patients about controlled substances. As I stepped into clinical practice and took over patients who had long-term relationships with providers that had retired or moved to other positions I began to notice a preponderance of patients, some elderly, taking benzodiazepines daily, frequently at high doses. Often conditions other than anxiety were being palliated with benzodiazepines to numb symptoms. Gradually escalating doses throughout years of daily use were evident as I examined their charts. All of this is in spite of clear direction that these medications are only for use in “severe, disabling anxiety or insomnia.”

As I spoke to these patients, took new histories and provided full informed consent on the risks, benefits, alternatives to their current medications another worrisome trend became evident. My patients had the perception that they had not received informed consent around their medications.

Informed consent in medicine is the process by which a patient is apprised of the risks, benefits, and alternatives to a procedure, treatment or medication they are considering. While it may be the case that in limited instances a previous provider practiced paternalistic medicine and abdicated this responsibility it is more likely that informed consent was provided to patients previously.  However, their perception that they are not receiving this information is especially worrisome when considering addictive medications that require careful management, such as benzodiazepines.

It is no secret that there is a critical shortage of psychiatrists in the United States and that this shortfall in practitioners is likely to worsen in the coming years. Predictions suggest that by 2024 we may have a deficit of more than 31,000 psychiatrists. The downstream effect of this need for more providers is that those of us currently in the workforce have large patient panels and an ever-growing need to see more patients. It can often feel like patient education, and difficult conversations are not allowed for in one’s daily clinic schedule. Time pressures can lead to avoidance of transitioning patients to safer alternatives to manage anxiety, setting firm limits around addictive medications, connecting them with therapists and groups (where available) and addressing the core issue the benzodiazepine is palliating. Just authorizing the refill of the ever-escalating dose of benzodiazepine can often seem to be the path of least resistance. In a climate where reducing burnout is a ubiquitous topic of conversation it can surely seem this time investment is overly burdensome.

I suggest revisiting patient education often and keeping tight controls on benzodiazepine use to unburden our system overall.  Our goal should be to carry educated panels of patients who are well managed, not dependent on inappropriate controlled substances and subject to the risk for falls, overdose, dementia and cognitive slowing posed by benzodiazepines. This will facilitate the next generation of psychiatrists stepping up to continue care and prevent needless iatrogenic harm that increases care burdens and cost to psychiatry and across specialties.

All of this is not to say that benzodiazepines should be avoided altogether.  To be sure, they are effective medications but almost universally the temporary or episodic basis on which they should be used is ignored. Safe prescribing practices, investing in the patient so they are an educated participant in their own care, treatment agreements explicitly reviewed with patients and documented, and encouraging adjunctive treatment (therapy, groups, exercise, diet) can only benefit patients and is in line with treatment recommendations. Considering the risks of these medications and that up to 20 percent of nationwide benzodiazepine consumption is “misuse” we are faced with a critical issue to take head-on as a profession if we are to claim we are doing our fiduciary duty to our patients and supporting each other as providers.

Samuel Ridout is a psychiatrist.

Image credit: Shutterstock.com

Prev

Change the approach to triage to alleviate ER overcrowding

April 15, 2019 Kevin 8
…
Next

Telemedicine and access: Leave no patient behind

April 15, 2019 Kevin 0
…

Tagged as: Psychiatry

Post navigation

< Previous Post
Change the approach to triage to alleviate ER overcrowding
Next Post >
Telemedicine and access: Leave no patient behind

Related Posts

  • Think beyond benzodiazepines for anxiety

    Wallace B. Mendelson, MD
  • Why your doctor may be concerned about prescribing benzodiazepines

    Arash Javanbakht, MD
  • Are benzodiazepines “the worst thing that’s ever happened to people”?

    Nicole Lamberson, PA
  • Stop cutting patients off their prescribed benzodiazepines

    Christy Huff, MD
  • Don’t miss this adverse drug reaction when tapering benzodiazepines

    Christy Huff, MD
  • Beware of online retailers selling designer benzodiazepines

    Abraham M. Nussbaum, MD

More in Meds

  • Can personalized medicine live up to its hype in health care?

    Ketan Desai, MD, PhD
  • The effects of the nationwide stimulant shortage on a private psychiatry practice

    Christine Tran-Boynes, DO
  • Why North American medical cannabis can’t compete globally

    Michael Sassano
  • How were we duped and what can we do about the opioid overdose crisis?

    Ronald A. Zent, MD
  • Caught in the middle: How health insurance companies influence cancer drug selection

    Paul Pender, MD
  • Timely treatment decisions: the promise of surrogate markers

    Layla Parast, PhD
  • Most Popular

  • Past Week

    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • From physician to patient: one doctor’s journey to finding purpose after a devastating injury

      Stephanie Pearson, MD | Physician
    • An unspoken truth about non-compete clauses in medicine

      Harry Severance, MD | Policy
    • Fostering the next (diverse) generation of clinicians

      Imamu Tomlinson, MD, MBA | Physician
    • Healing through love and spirituality

      John T. James, PhD | Conditions
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Why are doctors sued and politicians aren’t?

      Kellie Lease Stecher, MD | Physician
  • Recent Posts

    • Rescuing primary care: the role of health administrators [PODCAST]

      The Podcast by KevinMD | Podcast
    • Breaking down barriers: How technology is improving diabetes management in underserved communities

      Anonymous | Conditions
    • From penicillin to digital health: the impact of social media on medicine

      Homer Moutran, MD, MBA, Caline El-Khoury, PhD, and Danielle Wilson | Social media
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • How to overcome telemedicine’s biggest obstacles

      Harvey Castro, MD, MBA | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Investigational ALS Drug May Have Clinical Benefit, FDA Staff Says
  • Cases of Deadly Fungus Tripled in Past Few Years, CDC Says
  • Small Gains in Cardiorespiratory Fitness Track With Improved Longevity
  • Improved OS With Hyperfractionated RT in Recurrent Nasopharyngeal Carcinoma
  • GPT-4 Is Here. How Can Doctors Use Generative AI Now?

Meeting Coverage

  • Rapid Improvement in Atopic Dermatitis With Topical PDE4 Inhibitor
  • New Approaches in the Bladder-Sparing Paradigm
  • Response Rates in Hidradenitis Suppurativa Continue to Climb With New Therapies
  • Another Win for a JAK Inhibitor in Alopecia Areata
  • Biologic Switch Revs Up Response in Plaque Psoriasis
  • Most Popular

  • Past Week

    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • From physician to patient: one doctor’s journey to finding purpose after a devastating injury

      Stephanie Pearson, MD | Physician
    • An unspoken truth about non-compete clauses in medicine

      Harry Severance, MD | Policy
    • Fostering the next (diverse) generation of clinicians

      Imamu Tomlinson, MD, MBA | Physician
    • Healing through love and spirituality

      John T. James, PhD | Conditions
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • Why are doctors sued and politicians aren’t?

      Kellie Lease Stecher, MD | Physician
  • Recent Posts

    • Rescuing primary care: the role of health administrators [PODCAST]

      The Podcast by KevinMD | Podcast
    • Breaking down barriers: How technology is improving diabetes management in underserved communities

      Anonymous | Conditions
    • From penicillin to digital health: the impact of social media on medicine

      Homer Moutran, MD, MBA, Caline El-Khoury, PhD, and Danielle Wilson | Social media
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • How to overcome telemedicine’s biggest obstacles

      Harvey Castro, MD, MBA | Physician
    • Deaths of despair: an urgent call for a collective response to the crisis in U.S. life expectancy

      Mohammed Umer Waris, MD | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

It’s important to keep tight controls on benzodiazepines
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...